United Kingdom: A new approach to patent infringement

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

United Kingdom: A new approach to patent infringement

In a landmark decision on patent infringement (Actavis UK Limited v Eli Lilly & Company [2017] UKSC 48), the Supreme Court has confirmed that UK law does provide for a doctrine of equivalents when determining the scope of patent protection.

Prior to this decision, determining the issue of infringement in the UK required a "purposive" construction of the patent claims. In any purposive construction, the courts would establish the meaning of the claim language in the eyes of the skilled person, before deciding whether any alleged infringement fell within the scope of this meaning. If an alleged infringement was outside of this scope, there would be no infringement.

In other words, the language of the patent was considered to be of critical importance and, if the language of a claim could not be construed to extend to an equivalent, this equivalent did not represent an infringement. However, in the approach established by this recent decision, infringement may now arise even when the specific language of a claim would not be understood as extending to the alleged equivalent.

The Supreme Court judgment helpfully sets out guidance for determining whether there is infringement in such circumstances. In simple terms, for an equivalent to represent an infringement, the equivalent must obviously achieve the same result in the same way as the invention in the eyes of the skilled person when viewed at the priority date. Additionally, the skilled person must conclude there was no requirement for strict compliance with the literal meaning of the relevant claims. If these conditions are satisfied, the equivalent will represent an infringement.

While this most recent decision in July 2017 represents a new approach for the UK courts, this refreshed approach to equivalents is closely aligned with that taken by the German and Dutch courts. Accordingly, this decision can certainly be viewed as an attempt to align the interpretation of infringement across Europe before the first cases at the new Unified Patent Court.

Chapman

Helga Chapman

Chapman + Co

Kings Park House, 22 Kings Park Road

Southampton SO15 2AT

United Kingdom

Tel: +44 (0) 23 80000 2022

info@chapmanip.com  

www.chapmanip.com

more from across site and SHARED ros bottom lb

More from across our site

The chief technology officer remit, which has been created as the firm is building its litigation team, will include expanding the use of AI in patent and legal work and automating manual processes
Former Hoyng Rokh Moneiger partner Laura Alonso, who brought her team to ECIJA in March, discusses plans to expand further and why ECIJA’s ‘IP DNA’ is helping broaden her work
Amita Haylock discusses building an integrated Asia practice as clients increasingly demand that firms combine IP, technology and data expertise
François Pochart, Grégoire Desrousseaux and Lionel Martin, long-standing figures in the firm’s patent litigation team, are set to help launch a Paris-based litigation offering
The Unitary Patent has passed 100,000 registrations, but new data raises the question of whether 30% uptake is a ceiling or a staging post for further growth, say Michael Nielsen and Darren Smyth of EIP and Andrew Samm at Patently
The new generation of in-house IP leaders want commercial judgment, accessibility and flexibility, with AI raising expectations around both fees and delivery
The firm launched a San Diego office earlier this month, but California investment and expansion is far from complete
The industry’s response to AI requires an unfamiliar ingredient as firms battle to shape their futures
The firm is looking beyond replacing recently departed talent, betting instead on senior leaders to strengthen and expand its patent litigation platform
Olga Partington, director in Sterne Kessler’s biotechnology and chemical practice group, shares why a patent's vulnerability peaks when it is young, rather than when it is most valuable, under the PTAB's new framework
Gift this article